Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review

BACKGROUND: The optimal management of HBsAg-negative, anti-HBc-positive patients who receive immunosuppression remains unclarified. We systematically reviewed the available data on potential predictors of the risk of hepatitis B virus (HBV) reactivation in such patients. METHODS: A literature search...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ann Gastroenterol
Prif Awduron: Cholongitas, Evangelos, Haidich, Anna-Bettina, Apostolidou-Kiouti, Fani, Chalevas, Parthenis, Papatheodoridis, George V.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Hellenic Society of Gastroenterology 2018
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6033767/
https://ncbi.nlm.nih.gov/pubmed/29991894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20524/aog.2018.0266
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg